HALO

Halozyme Therapeutics INC

-$485.1M

Net Activity

Institutions Holding

630

Popularity Rank

#838

Avg Weight

0.12%

Total Value

$7.8B

Ownership Trend

630 institutions currently hold HALO, with 320 net buyers and 280 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

280

Net Buying Institutions

320

Key Holders

Key Holders

Top 5 by Value

BI
BlackRock, Inc.
$857.3M
VC
Vanguard Capital Management LLC
$340.7M
VP
Vanguard Portfolio Management LLC
$339.3M
SS
State Street CORP
$319.1M
IL
Invesco Ltd.
$259.3M

Top 5 by Conviction

SC
Snyder Capital Management L P
2.91%
MM
Mizuho Markets Americas LLC
2.34%
SI
Stephens Investment Management Group LLC
1.08%
GI
GW&K Investment Management, LLC
0.79%
CA
Congress Asset Management Co
0.59%
View all 630 holding institutions

Quarterly Activity

Recent Activity

+$4.5B

Total Buy Value

$3.8B

Total Sell Value

New buy83
Trim212
Add237
Sold out68

320

Net Buyers

280

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$548K

Total Est. Value

7K shares

Planned Shares

Last Filed 2026-06-29
FilerFiling DateEst. Value
Krishnan Mahesh2026-06-29$548K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-07-02
2026-07-02

Halozyme Therapeutics announced on June 30, 2026, that its Chief Operating Officer, Cortney Caudill, is leaving the company. The announcement also mentioned an update to the senior management structure. The company thanked Ms. Caudill for her contributions.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding HALOZYME THERAPEUTICS INC (HALO)?
Major stakeholders currently include BlackRock, Inc. ($857.3M), Vanguard Capital Management LLC ($340.7M), Vanguard Portfolio Management LLC ($339.3M). Based on the latest 13F filings, there are a total of 630 tracked investment funds and institutions maintaining positions in HALO.
What is the overall institutional sentiment toward HALO recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $485.1M, driven by 320 managers accumulating shares while 280 reduced their exposure.
Which institutions have been selling or reducing their HALO positions?
In the latest period, 212 funds trimmed their holdings, and 68 managers completely exited their positions. The aggregate reported sell value was $3.8B.
Are there any notable investors adding HALO to their portfolios?
Yes, buying activity remains notable. 83 institutions opened new positions in {ticker}, and 237 existing holders added to their shares. The total reported buy value for the quarter amounted to $4.5B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,603

Total reported value

$438.8B

572 institutions currently hold both HALO and this stock

View detail
LLY

Eli Lilly & Co

Institutions Holding

4,337

Total reported value

$730.5B

579 institutions currently hold both HALO and this stock

View detail
ABBV

Abbvie INC

Institutions Holding

4,024

Total reported value

$283.9B

558 institutions currently hold both HALO and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter

View detail